Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 2 | M/S S.K. MEDICAL STORE | 1 | ₹1.2 L |
| 2 | Schedule 4 | M/S S.K. MEDICAL STORE | 1 | ₹20,000 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
17 Mar 2022, 12:00 pmClosed
CYPROHEPTADINE+ LYSINE ALL STRENGTH SYRUP in100 ml btl (Q3)
COUGH SYRUP - CONTAINING MINIMUM INGREDIENT IN EACH 1/5/10ML OF FOLLOWING: TERBUTALINE+ GUAIPHENESIN+ (Q3)
PEPSIN+ FUNGAL DIASTASE ALL STRENGTH CAPSULE (Q3)
TRAMADOL+ PARACETAMOL 37.50+ 325 mg TABLET (Q3)
3178657
GEM/2022/B/1976364
CYPROHEPTADINE+ LYSINE ALL STRENGTH SYRUP in100 ml btl,COUGH SYRUP - CONTAINING MINIMUM INGREDIENT
Unknown (Unspecified Location)
Item wise evaluation
PRODUCT_CUSTOM
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| CYPROHEPTADINE+ LYSINE ALL STRENGTH SYRUP in100 ml btl (Q3) | - | - | - |
| COUGH SYRUP - CONTAINING MINIMUM INGREDIENT IN EACH 1/5/10ML OF FOLLOWING: TERBUTALINE+ GUAIPHENESIN+ (Q3) | - | - | - |
| PEPSIN+ FUNGAL DIASTASE ALL STRENGTH CAPSULE (Q3) | - | - | - |
| TRAMADOL+ PARACETAMOL 37.50+ 325 mg TABLET (Q3) | - | - | - |
Exempted
26 Apr 2022
24 Feb 2022
17 Mar 2022
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_3178657.pdf
GEM_BID
item-no-1_2022-02-21-10-41-09_844e639e4e86810bb292ee79f9dde598.pdf
SPECIFICATION
item-no-2_2022-02-21-10-42-24_2df72df94f44f0550215155d6ea26692.pdf
SPECIFICATION
item-no-3_2022-02-21-10-43-59_62f65ba740336f0e6571e3105b6b8c5b.pdf
SPECIFICATION
item-no-4_2022-02-21-10-45-22_3eb65f0579b4ddeb0fa0335bba7fb4ea.pdf
SPECIFICATION
1645510656.pdf
OTHER
termsCondition.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .